Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Dr. Yu-Tzu Tai, PhD of the Dana-Farber Cancer Institute, Boston, MA describes how CAR-T cells may be used to reduce the toxic effects of therapy and the promise of new antibody-drug conjugates. Recorded at the International Myeloma Workshop (IMW) 2019, in Boston, MA.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.